AI assistant
Microbot Medical Inc. — Director's Dealing 2016
Jan 5, 2016
33819_dirs_2016-01-05_3151fe3e-b7d1-4d60-921d-5ebe3b4bff19.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-01-01
Reporting Person: WEISSMAN IRVING (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-01 | Common Stock | A | 146342 | $0.00 | Acquired | 480449 | Direct |
| 2016-01-01 | Common Stock | A | 29762 | $0.00 | Acquired | 510211 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22471 | Indirect |
Footnotes
F1: In accordance with Board action taken, this is an equity grant of 146,342 restricted stock units, vesting 100% on January 1, 2017, as compensation for Board service.
F2: Includes the following anniversary equity grant: 146,342 restricted stock units vesting 100% on January 1, 2017.
F3: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service on the Company's Scientific Advisory Board.
F4: Includes 10,508 shares held in trust for Dr. Weissman's grandchildren. Dr. Weissman disclaims beneficial ownership of such shares